Skip to main content
Deutsch

Clinical & Epidemiological Science Unit

Director: Assoc. Prof. Peter Mandl
  1. Department of Medicine III
  2. Our departments
  3. Rheumatology
  4. Research
  5. Clinical & Epidemiological Science Unit

Latest Research

The synovial interface: At the intersection from cells to humans. Annals of Anatomy, April 2026

An international, multicentre, interventional, randomised, assessor-blinded trial to MAXimise the METHotrexate therapy potential in patients with active rheumatoid arthritis (MethMax trial): study protocol for a randomised controlled trial. Trials, March 2026

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update. Annals of the Rheumatic Diseases, March 2026. Media coverage:1, 2, 3, 4, 5, 6

International IVIg prescription patterns in idiopathic inflammatory myopathies: real-world insights from the MyoNet survey. EULAR Rheumatology Open, March 2026

Do high rheumatoid factor levels impact response to certolizumab pegol in patients with inadequately controlled rheumatoid arthritis? A post hoc analysis of the phase IIIb REALISTIC trial. RMD Open, January 2026

Research Group of Helga Lechner-Radner

Outcome Research in Rheumatology

We stand at the forefront of bridging clinical trials, digital health, and patient-centered outcome research, making every step in rheumatology care more evidence-based, precise, and meaningful for patients.

To the Research Group

Research Group of Peter Mandl

Rheumatology Imaging Group Vienna (RIG Vienna)

We perform and interpret imaging studies encompassing all manifestations of rheumatic and musculoskeletal diseases and develop new diagnostic and therapeutic methods targeting fibroblasts.

To the research group

Research Group of Daniela Sieghart

Biomarkers in rheumatic disorders

We study autoantibodies as potential biomarkers for diagnosis, management and prognosis of rheumatic conditions.

To the Research Group

Research Group of Paul Studenic

We try to understand the validity of outcomes used in measuring disease activity, progression, quality of life and the interaction of patients with the health care system.

To the Research Group

Research Group Autoimmunity and Immunodeficiency

We study, treat and manage patients with immune mediated inflammatory diseases as well as patients with primary or secondary immunodeficiencies.

To the Research Group

Research Group RHEPRO

RHEumatic disease and RePROduction

We conduct translational research on the impact of rheumatic diseases on fertility, pregnancy, and the development of the fetal and neonatal immune system, and develop interdisciplinary strategies to improve diagnostics, therapy, and patient care.

To the research group